MRGPRX2 Antagonism in Chronic Spontaneous Urticaria: Phase 2 Randomized CALM ‐ CSU Study Results
Allergy · 2026-10-29
DOI: 10.1111/all.70547 ↗At a glance
Journal article in Allergy, published online on 2026-10-29. Written by Martin Metz and 5 co-authors. Institution: Institute of Allergology, Charité - University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin…. 5 references. The full text is freely available (open access, CC BY 4.0). Funded by: Escient Pharmaceuticals.
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Institute of Allergology, Charité - University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
- Department of Dermatology, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
- Incyte Corporation, Wilmington, Delaware, USA.
- Escient Pharmaceuticals (a subsidiary of Incyte Corporation), San Diego, California, USA.
ORCID profiles: Martin Metz, Manuel P Pereira, Ana Giménez-Arnau, Qi Yan
Funding
- Escient Pharmaceuticals
Cite
APA
Metz, M., Pereira, M. P., Giménez-Arnau, A., Yan, Q., Weyer, C., & Kim, T. (2026). MRGPRX2 Antagonism in Chronic Spontaneous Urticaria: Phase 2 Randomized CALM ‐ CSU Study Results. Allergy. https://doi.org/10.1111/all.70547
Vancouver
Metz M, Pereira MP, Giménez-Arnau A, Yan Q, Weyer C, Kim T. MRGPRX2 Antagonism in Chronic Spontaneous Urticaria: Phase 2 Randomized CALM ‐ CSU Study Results. Allergy. 2026. doi:10.1111/all.70547
BibTeX
@article{Metz2026,
author = {Metz, Martin and Pereira, Manuel P and Giménez-Arnau, Ana and Yan, Qi and Weyer, Christian and Kim, Terri},
title = {MRGPRX2 Antagonism in Chronic Spontaneous Urticaria: Phase 2 Randomized CALM ‐ CSU Study Results},
journal = {Allergy},
year = {2026},
doi = {10.1111/all.70547}
}
EUVIMED